Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026)

Recursion Pharmaceuticals (RXRX) has 4 years of Tax Rate data on file, last reported at 3.77% in Q1 2026.

• Quarterly Tax Rate rose 369.0% year-over-year to 3.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.81% (up 72.0% YoY) and the FY2025 annual result came in at 0.02%, down 22.0% from the prior year.
• Tax Rate grew to 3.77% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 4.19% in Q4 2023 to a low of 0.17% in Q3 2024.
• A 4-year average of 1.02% and a median of 0.08% in 2025 frame the typical range for Tax Rate.
• Annual changes were most pronounced in 2024 — Tax Rate slumped 419 bps — and 2026, when it surged 369 bps.
• Tracing RXRX's Tax Rate over 4 years: stood at 4.19% in 2023, then sank by 100 bps to 0.0% in 2024, then sank by 373 bps to 0.02% in 2025, then soared by 20480 bps to 3.77% in 2026.
• The last three Tax Rate figures came in at 3.77% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.